The technology solves the cost and scale problem in oncology. Instead of expensive lab tests, GigaTIME uses deep learning algorithms to "inpainting" invisible immune system markers onto ordinary slides. This allows doctors to analyze tumor-immune interactions at a population level (tens of thousands of patients) with unprecedented speed.
Source: Cell / PubMed
MedTechScienceOncologyCellResearch